Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluation of Ascorbate-Meglumine Therapeutic for SRS
Phase 1
Not yet recruiting
- Conditions
- Safety
- Interventions
- Drug: Ascorbate-Meglumine
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- LadeRx LLC
- Target Recruit Count
- 12
- Registration Number
- NCT06433791
- Locations
- 🇺🇸
Duke Health, Durham, North Carolina, United States
News
No news found